Share the Video:

Delivering patient-centered care in a profit-focused world

Nathan Sackett, Kimberly Roddy, Le Ondra Clark Harvey, Deidra Somerville, Tyler Norris

It is no secret that the United States struggles to deliver accessible, equitable, cost-effective mental and physical healthcare, and that the needs of patients, and priorities of industry, are often misaligned. We will hear from leaders envisioning and operating systems of care that center the interests of patients, informing how businesses can flourish in a well-being economy.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

The drug policy endgame: beyond public health

Seasoned leaders and activists delve into redefining drug policy, focusing on social justice, human rights, and harm reduction for a compassionate, equitable future. Join the discussion for transformative approaches.

Shaleen Title, Kassandra Frederique, Jason Ortiz

PS2023 Health Equity Indigenous People Policy and Advocacy Psychedelic Science Public Benefit Social Justice

Reflections on Psychedelic Science 2023

Key themes at Psychedelic Science 2023 included examining access, affordability, and reciprocity. The community was urged to address the impact of colonial systems on Indigenous communities and ensure equity for

Marwan and Noam, Snow Raven

PS2023 Business Harm Reduction Policy and Advocacy Public Benefit Research and Science Social Justice

Growing up: The next cycle of venture funding for psychedelic companies

Commercial investment dominates psychedelic sector funding, primarily for drug discovery. Non-commercial projects need financial backing for drug policy reform, public health education, harm reduction, and diversity initiatives. Strategic funding can

Daniel Goldberg, Andrew Chomer, Lindsay Hoover, Sasha Cohen

PS2023 Health Equity Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Psychedelic social equity, criminal justice, and sentencing reform

Visionary advocates, activists, and policy experts discuss rectifying historical injustices and disparities from psychedelic criminalization. Conversations focus on social equity, criminal justice reform, and sentencing for legal infrastructure changes.

Kellen Russoniello, Rachel Knox, Sia Henry

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Designing a post-prohibition future

Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.

Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Visionary approaches: psychedelic policy in a global context

International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.

Steve Rolles, Kasia Malinowska

PS2023 Healing for All Health Equity Policy and Advocacy Psychedelic Science Psychedelic-AT Public Benefit

Regulating State Markets for Psychedelic-Assisted Services

Regulators discuss state frameworks for psychedelic healing to ensure success, equity, and safety in the industry. Various perspectives on the new programs are explored.

Dominique D Mendiola

PS2023 Harm Reduction Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Giving and growth: the role of philanthropic funding in the psychedelic sector

Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.

Sandy Samberg

Delivering patient-centered care in a profit-focused world

Become a MAPS Member with a monthly donation

Related Videos